Nava Therapeutics Emerges With $89M for Precision RNA-LNP Delivery
Nava Therapeutics disclosed $89 million in financing to advance a precision lipid-nanoparticle platform designed to deliver RNA beyond the liver, including to immune cells and kidney tissue. The company is developing in vivo CAR-T…
